Skip to main content

Drug Safety

Ausgabe 3/2016

Inhalt (9 Artikel)

Review Article

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

Joshua B. French, Maurizio Bonacini, Marwan Ghabril, David Foureau, Herbert L. Bonkovsky

Open Access Original Research Article

Post-Marketing Benefit–Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis

Edouard Ledent, Alfons Lieftucht, Hubert Buyse, Keiji Sugiyama, Michael Mckenna, Katsiaryna Holl

Open Access Original Research Article

Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter

Abeed Sarker, Karen O’Connor, Rachel Ginn, Matthew Scotch, Karen Smith, Dan Malone, Graciela Gonzalez

Original Research Article

Clinicians’ Reports in Electronic Health Records Versus Patients’ Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin

Maxim Topaz, Kenneth Lai, Neil Dhopeshwarkar, Diane L. Seger, Roee Sa’adon, Foster Goss, Ronen Rozenblum, Li Zhou

Original Research Article

A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases

Mickael Arnaud, Francesco Salvo, Ismaïl Ahmed, Philip Robinson, Nicholas Moore, Bernard Bégaud, Pascale Tubert-Bitter, Antoine Pariente

Original Research Article

Use of Prescription Drug Samples in the USA: A Descriptive Study with Considerations for Pharmacoepidemiology

Christian Hampp, Patty Greene, Simone P. Pinheiro

Meeting Report

The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015

Roni P. Dodiuk-Gad, Cristina Olteanu, Wen-Hung Chung, Neil H. Shear